NEW BRUNSWICK, N.J. -- Johnson & Johnson (JNJ) said Saturday that it completed its tender offer for shares of Omrix Biopharmaceuticals Inc. (OMRI), a New York-based maker of liquid sealants used to control bleeding during surgery.J&J said Omrix shareholders tendered about 97.8% of shares in response to a tender offer that expired at midnight Friday.
J&J Completes Omrix Tender Offer
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
Every recommendation goes through 3 layers of intense scrutinyquantitative, fundamental and technical analysisto maximize profit potential and minimize risk.
Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.